{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T20:02:32Z","timestamp":1785614552500,"version":"3.56.0"},"reference-count":10,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2023,11,26]]},"DOI":"10.3960\/jslrt.23041","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T22:12:28Z","timestamp":1703542348000},"page":"251-256","source":"Crossref","is-referenced-by-count":8,"title":["Methotrexate-induced subacute myelopathy: a serious but treatable complication"],"prefix":"10.3960","volume":"63","author":[{"given":"Takashi","family":"Miyoshi","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Shiga General Hospital, Moriyama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan,"},{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kitawaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto University, Kyoto Graduate School of Medicine, Kyoto, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Yoshinaga","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Shiga General Hospital, Moriyama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Oka","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Shiga General Hospital, Moriyama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohsuke","family":"Asagoe","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Shiga General Hospital, Moriyama, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Imashuku","sequence":"additional","affiliation":[{"name":"Department of Hematology, Uji Tokushukai Medical Center, Uji, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Afshar M, Birnbaum D, Golden C. Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity. Pediatr Neurol. 2014; 50: 625-629.","DOI":"10.1016\/j.pediatrneurol.2014.01.048"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Vagace JM, de la Maya MD, Caceres-Marzal C, Gonzalez de Murillo S, Gervasini G. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia\/lymphoma. Crit Rev Oncol Hematol. 2012; 84: 274-286.","DOI":"10.1016\/j.critrevonc.2012.04.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Cachia D, Kamiya-Matsuoka C, Pinnix CC <i>et al.<\/i> Myelopathy following intrathecal chemotherapy in adults: a single institution experience. J Neurooncol. 2015; 122: 391-398.","DOI":"10.1007\/s11060-015-1727-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ackermann R, Semmler A, Maurer GD <i>et al.<\/i> Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites. J Neurooncol. 2010; 97: 425-427.","DOI":"10.1007\/s11060-009-0028-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Vezmar S, Becker A, Bode U, Jaehde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy. 2003; 49: 92-104.","DOI":"10.1159\/000069773"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Maruyama D, Watanabe T, Maeshima AM <i>et al.<\/i> Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)\/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL. Int J Hematol. 2010; 92: 732-743.","DOI":"10.1007\/s12185-010-0728-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Saviola G, Abdi-Ali L, Sacco S <i>et al.<\/i> Complete clinical and functional recovery following low-dose methotrexate related paraparesis in a patient with compound c.1298A&gt;C AND c.677C&gt;T MTHFR polymorphism: A case report. Medicine (Baltimore). 2018; 97: e13350.","DOI":"10.1097\/MD.0000000000013350"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado ZMN. Potential outcome factors in subacute combined degeneration: review of observational studies. J Gen Intern Med. 2006; 21: 1063-1068.","DOI":"10.1111\/j.1525-1497.2006.00525.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Wolff L, Zighelboim J, Gale RP. Paraplegia following intrathecal cytosine arabinoside. Cancer. 1979; 43: 83-85.","DOI":"10.1002\/1097-0142(197901)43:1<83::AID-CNCR2820430112>3.0.CO;2-S"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Rydberg B, Lindahl T. Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction. EMBO J. 1982; 1: 211-216.","DOI":"10.1002\/j.1460-2075.1982.tb01149.x"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/4\/63_23041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:17:58Z","timestamp":1715577478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/63\/4\/63_23041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,26]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.23041","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,26]]},"article-number":"23041"}}